Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for ACS patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double blinded, placebo controlled randomized trial

Publication date: Available online 9 July 2020Source: American Heart JournalAuthor(s): Yi Li, Quanmin Jing, Bing wang, Xiaozeng Wang, Jing Li, Shubing Qiao, Shaoliang Chen, Dominick J. Angiolillo, Yaling Han
Source: American Heart Journal - Category: Cardiology Source Type: research